Figure 1

Relative levels of SLC39A12 variant 1 (a, b and c) and variant 2 (d, e and f) mRNA (median±interquartile range) in BA 8 (a and d), 9 (b and e) and 44 (c and f) from subjects with schizophrenia and age-/sex-matched control subjects as well as subjects with schizophrenia divided into MRDS and non-MRDS. Probability values in brackets were obtained after analyzing SLC39A12 variant 1 and 2 with potential confounds included as covariates MDRS, muscarinic receptor deficit schizophrenia; mRNA, messenger RNA.